title: [Immunmodulatory antibodies in the treatment of skin cancer].
abstract: Since the efficacy of conventional therapeutic approaches is limited in patients with solid tumors, especially melanoma, there is a need for alternatives. Because of the immunogenicity of melanoma, immunotherapeutic approaches have been widely tested. Among others, therapeutic antibodies have been used. These can be distinguished by their modus operandi, e.g. induction of cellular or complement-dependent cytotoxicity against tumor cells, or modification of immune responses. The latter can be achieved by blockage of inhibitory signal pathways or stimulation of excitatory signal pathways of immune response. We discuss the immunomodulatory antibodies which are currently in clinical testing.
authors.affiliation: Klinik für Dermatologie, Allergologie und Venerologie, Universitätshautklinik Würzburg, Josef-Schneider-Strasse 2, 97080, Würzburg, Deutschland.
authors.forename: D
authors.initials: D
authors.lastname: Schrama
authors.forename: A
authors.initials: A
authors.lastname: Hauschild
authors.forename: J C
authors.initials: JC
authors.lastname: Becker
mesh_terms: D000906:Antibodies / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D000906:Antibodies
references.citation: N Engl J Med. 2006 Sep 7;355(10):1018-28
references.pmid: 16908486
references.citation: J Clin Oncol. 2004 Nov 15;22(22):4463-73
references.pmid: 15483010
references.citation: Int Immunol. 2005 Feb;17(2):133-44
references.pmid: 15611321
references.citation: Nat Med. 1999 Jul;5(7):774-9
references.pmid: 10395322
references.citation: Crit Rev Immunol. 2007;27(5):415-36
references.pmid: 18197805
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4712-7
references.pmid: 12682289
references.citation: Annu Rev Immunol. 2001;19:565-94
references.pmid: 11244047
references.citation: Nat Immunol. 2007 Mar;8(3):239-45
references.pmid: 17304234
references.citation: Annu Rev Immunol. 2005;23:23-68
references.pmid: 15771565
references.citation: Biotechnology. 1992;24:524-6
references.pmid: 1422065
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3005-10
references.pmid: 18287062
references.citation: Cancer Metastasis Rev. 2005 Dec;24(4):585-98
references.pmid: 16408163
references.citation: Gene Ther. 2005 Oct;12(20):1526-33
references.pmid: 15973445
references.citation: J Mol Med (Berl). 2006 Sep;84(9):726-36
references.pmid: 16924475
references.citation: Int Immunol. 1998 Apr;10(4):453-61
references.pmid: 9620601
references.citation: N Engl J Med. 2006 Sep 7;355(10):973-5
references.pmid: 16908487
references.citation: Int J Cancer. 2006 Jul 15;119(2):317-27
references.pmid: 16482562
references.citation: Blood. 1997 Jul 15;90(2):549-61
references.pmid: 9226154
references.citation: Cancer. 2007 Dec 15;110(12):2614-27
references.pmid: 18000991
references.citation: J Immunol. 2000 Jun 15;164(12):6633-9
references.pmid: 10843723
references.citation: Cancer Immunol Immunother. 2008 Jan;57(1):19-29
references.pmid: 17564702
references.citation: Annu Rev Immunol. 2005;23:515-48
references.pmid: 15771580
references.citation: Curr Opin Immunol. 2006 Apr;18(2):206-13
references.pmid: 16464564
references.citation: J Clin Oncol. 2007 Mar 1;25(7):876-83
references.pmid: 17327609
references.citation: Immunol Cell Biol. 2005 Aug;83(4):344-51
references.pmid: 16033529
references.citation: Int Immunol. 2007 Oct;19(10):1223-34
references.pmid: 17898045
references.citation: Nat Med. 1999 Jul;5(7):780-7
references.pmid: 10395323
references.citation: N Engl J Med. 2004 Mar 11;350(11):1079-80
references.pmid: 15014180
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8785-90
references.pmid: 9671756
references.citation: Nat Rev Drug Discov. 2006 Feb;5(2):147-59
references.pmid: 16424916
references.citation: Int J Cancer. 2004 Apr 20;109(4):499-506
references.pmid: 14991570
references.citation: J Immunol Methods. 2001 Feb 1;248(1-2):139-47
references.pmid: 11223075
references.citation: Trends Immunol. 2007 Feb;28(2):48-50
references.pmid: 17188572
references.citation: J Biol Chem. 2005 Dec 16;280(50):41472-81
references.pmid: 16204238